Skip to content
PaperFren

Research method

Mass Spectrometry Proteomics

Mass-spectrometry proteomics identifies and, when labelled or quantified, counts peptides from a protein mixture after proteolytic digestion. Outputs range from a subcellular inventory (who is on this membrane face) to site maps of modifications (ubiquitin, lysine crotonylation) to subunit stoichiometry of a purified complex. An identified peptide is not a phenotype, and genome papers in this list are not proteomic experiments.

Cell biologists use MS when fractionation or antibodies cannot resolve a compartment or a modification site. It answers 'which proteins or modified lysines are in this sample?' The main limitation is that enrichment is not functional proof, and several lexicon hits here are genomes or transcriptomes that never ran a mass spectrometer on peptides.

Studies

7

Findings

5

7 supporting · 0 challenging · 0 qualifying citations

Open tensions

2

Currently

What we know

  1. APEX2 proximity labelling in living cells defined cytosol-facing proteomes of the outer mitochondrial membrane and the ER membrane: expected functional classes plus many additions (22 OMM proteins; 72 ERM proteins), beyond classical fractionation. The inventory is not a full functional validation of every newly enriched protein.
  2. Purified caveolar coats analysed by quantitative composition showed caveolins and cavins as one complex excluding EHD2/pacsin 2, with Cavin 1 a core component and evidence for trimers. MS-backed stoichiometry is a biochemical model, not a dynamics movie in every cell type.
  3. Rab5 monoubiquitination sites were mapped at K116, K140 and K165; chemically monoubiquitinated Rab5 then showed that K140/K165 downregulate the endocytic pathway via disrupted effectors and nucleotide conversion, while K116 has little localisation effect. Site-resolved MS (or MS-informed chemistry) here is a modification map, not an identification of the endogenous E3 ligase.
  4. In rice, MS plus ChIP-seq mapped histone lysine butyrylation and crotonylation: many Kcr sites on H3/H4, with Kbu/Kcr resembling acetylation distribution and changing with metabolic stress. Occupancy dynamics are not proof that every site is required for a named stress phenotype.
  5. Three papers are false-positive lexicon hits for proteomics. Naegleria fowleri work assembled an ~30 Mb AT-rich genome and listed candidate pathogenicity genes; Aspergillus comparative genomics reported ~29–36 Mb genomes with 9,113–13,553 genes (~20% Aspergillaceae-specific; section Nigri ~1,800 unique genes); Plasmodium falciparum IDC transcriptome was hourly expression across a ~48-hour blood-stage cycle. Those are DNA or RNA catalogues, not peptide spectra.

Largest unresolved question

Genuine MS designs still disagree about what is being counted. APEX2 inventories membrane-face neighbours in living cells (22 OMM; 72 ERM); caveolar work quantifies a purified coat; Rab5 work maps three ubiquitin lysines; rice work maps histone acylations under stress. A 'proteomics paper' can be spatial, stoichiometric, or epigenetic, and those outputs are not interchangeable.

Procedure

How it works

The main stages of the method. Specific protocols and analysis choices vary between studies.

  1. Digest the protein mixture

    Proteins from a lysate, a proximity-labelled compartment, or a purified complex are cut into peptides. What never entered the digest cannot be identified later.

  2. Separate and ionise peptides

    Peptides are usually chromatographed then ionised into a mass spectrometer. Genome or transcriptome papers tagged for this method never took this step.

  3. Match spectra to sequences

    Fragment ions are identified as peptides. An identified peptide is a sequence in this sample, not a phenotype and not functional proof that the protein acts on that membrane face.

  4. Quantify proteins, sites, or stoichiometry

    Outputs range from a subcellular inventory to ubiquitin or crotonylation site maps to subunit ratios of a coat. Site-specific chemistry, not a bulk spectral count, is what distinguishes a Rab5 lysine that downregulates endocytosis from one that does not.

  5. Treat an identified peptide as inventory, not a phenotype

    MS proteomics answers which proteins or modified lysines are in this sample. Enrichment is a location hypothesis; candidate gene lists from sequenced genomes are not peptide identifications.

Common misconceptions

  • If APEX2 enriches a protein on the OMM or ERM, that protein's function on that face is known.

    The maps capture expected classes and add 22 OMM and 72 ERM proteins beyond classical fractionation. Enrichment is a location hypothesis, not functional validation of each new protein.

  • Detecting ubiquitin on Rab5 is enough to say the GTPase is off.

    K140 and K165 modifications downregulate endocytosis; K116 has little localisation effect. Site-specific chemistry, not a bulk ubiquitin spectral count, made that distinction.

  • A pathogenicity-factor 'proteome' of Naegleria was measured because the paper is tagged for mass spectrometry.

    The study sequenced and assembled an ~30 Mb AT-rich genome and nominated candidate genes. Those candidates still need functional validation in infection models and are not peptide identifications.

Related